HKG/2315 (HKG/2315)

Hong Kong Stock Exchange: HKG/2315 · HKD

HK$42.9

+2.90 (+7.2%)· Recorded snapshot

Market cap	37.9B
Revenue (ttm)	2B
Net income (ttm)	422.9M
EPS (ttm)	HK$0.99
Shares out	446.9M
P/E (trailing)	43.3x
P/E (forward)	39.6x
Volume	2,473,500
Beta	0.01

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2B
Net income (ttm): 422.9M
EPS (ttm): HK$0.99
P/E (trailing): 43.3x
P/E (forward): 39.6x
Market cap: 37.9B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E39.6

P25 n/aP50 n/aP75 n/a

Trailing P/E43.3

P25 n/aP50 n/aP75 n/a

ROE22

P25 n/aP50 n/aP75 n/a

ROIC20

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All HKG/2315 indicators

Market & fundamental data

Available fields

220

Groups with data

Currency

CNY

Showing 220 of 220 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	HKD
Country	China
Country code	HK
Earnings date	2026-10-29
Employees	1,922
Employees change	479
Employees growth	33.19%
Enterprise value	HKD 37.5B
Exchange	Hong Kong Stock Exchange
Financial currency	CNY
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2008
Industry	Biotechnology
Is primary listing	Yes
ISIN number	CNE100005D27
Last earnings date	2026-08-27
Last refreshed	2026-10-28
Market cap	HKD 37.9B
Next earnings date	2026-10-29
Price	HKD 42.94
Price currency	HKD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	hkg/2315
Website	https://biocytogen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	2.31%
EV/Earnings	82.55x
EV/EBIT	72.83x
EV/EBITDA	55.54x
EV/FCF	199.41x
EV/Sales	17.8x
FCF / EV yield	0.5%
FCF yield	0.5%
Forward P/E	39.58x
Graham number	11.8148
Graham upside	-72.23%
Industry forward P/E	44.68x
Industry P/E	134x
P/(FCF - SBC) ratio	262.83x
P/(OCF - SBC) ratio	77.82x
P/B ratio	12.61x
P/E ratio	43.3x
P/FCF ratio	201.75x
P/OCF ratio	71.42x
P/S ratio	18x
Price / tangible book value	12.69x
Price/EBITDA ratio	58.27x
Sector forward P/E	23.95x
Sector P/E	41.75x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	24.94%
EBITDA margin	30.9%
Effective tax rate	2.83%
FCF margin	8.76%
Gross margin	78.6%
Operating margin	24.94%
Pretax margin	22.19%
Profit margin	21.56%
Profit per employee	HKD 220,020
Profitable quarters	4
Profitable years	2
Revenue per employee	HKD 1M
ROA	8.64%
ROA (5Y)	-5.62%
ROCE	13.48%
ROE	22.05%
ROE (5Y)	-22.85%
ROIC	20.01%
ROIC (5Y)	-30.37%
SBC / revenue	2.07%
Tax / revenue	0.63%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	171.76%
EPS growth (Q)	80.71%
EPS growth (QoQ)	37.1%
EPS growth quarters	7
EPS growth years	3
FCF growth	-55.22%
FCF growth (Q)	-98.59%
FCF growth (QoQ)	-94.61%
Gross profit growth	44.21%
Gross profit growth (Q)	48.25%
Gross profit growth 3Y	43.2%
Net income growth	177.05%
Net income growth (Q)	123.79%
Net income growth (QoQ)	31.75%
Net income growth quarters	7
Net income growth years	3
OCF growth	11.25%
OCF growth (Q)	-31.13%
OCF growth (QoQ)	-19.46%
Operating income growth	88.37%
Operating income growth (Q)	99.25%
Revenue growth	42.68%
Revenue growth (Q)	36.79%
Revenue growth (QoQ)	17.38%
Revenue growth 3Y	39.08%
Revenue growth quarters	7
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	HKD -319.5M
Depreciation and amortization	HKD 119M
EBIT	HKD 489.3M
EBITDA	HKD 606.1M
EPS	HKD 0.99
FCF per share	HKD 0.39
Financing cash flow	HKD 628.9M
Free cash flow	HKD 175.1M
Free cash flow minus SBC	HKD 134.4M
Gross profit	HKD 1.5B
Income taxes	HKD 12.3M
Investing cash flow	HKD -691.9M
Net borrowing	HKD -298.1M
Net cash flow	HKD 425.4M
Net income	HKD 422.9M
Operating cash flow minus SBC	HKD 453.9M
Operating income	HKD 489.3M
Revenue	HKD 2B
Stock-based compensation	HKD 40.7M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	11.48
Book value per share	HKD 6.26
Debt / EBITDA	1.25
Debt / equity	0.29
Debt / FCF	4.57
Interest coverage	5.96
Long-term assets	HKD 2.2B
Long-term liabilities	HKD 817.6M
Net cash (debt)	HKD 415.1M
Net cash / market cap	1.18%
Net debt / EBITDA	-0.68
Net debt / equity	-0.15
Net debt / FCF	-2.37
Piotroski F-Score	8
Property, plant and equipment	HKD 2.1B
Shareholders' equity	HKD 2.8B
Tangible book value	HKD 2.8B
Tangible book value per share	HKD 6.23
Total assets	HKD 4.2B
Total cash	HKD 1.2B
Total debt	HKD 800.6M
Total liabilities	HKD 1.4B
WACC	4.43%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.55
Current assets	HKD 2B
Current liabilities	HKD 586.7M
Current ratio	3.42
Inventory turnover	35.74
Net working capital	HKD 241M
Quick ratio	2.79
Working capital	HKD 1.4B
Working capital turnover	2.42

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-1.95%
Payout ratio	4.11%
Shareholder yield	-1.95%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	HKD 54.67
1D price change	7.24%
1M price change	-37.13%
1M total return	-37.13%
1W price change	-5.58%
1W total return	-5.58%
1Y price change	68.66%
1Y return CAGR	68.72%
1Y total return	68.66%
20-day SMA	HKD 56.91
200-day SMA	HKD 52.85
3M price change	-20.63%
3M total return	-20.63%
3Y price change	263.9%
3Y return CAGR	53.8%
3Y total return	263.9%
50-day SMA	HKD 59.94
50-day SMA vs 200-day SMA	50over200
52-week high	HKD 80.65
52-week high date	2026-10-06
52-week low	HKD 23.94
52-week low date	2025-10-30
6M price change	-27.03%
6M total return	-27.03%
All-time high	HKD 80.65
All-time high date	2026-10-06
All-time low	HKD 5.60
All-time low date	2024-11-14
Average true range (ATR)	HKD 5.01
Average volume	2.3M
Beta (1Y)	0.72
Beta (2Y)	0.61
Beta (5Y)	0.01
Change from 52-week high	-46.76%
Change from 52-week low	79.37%
Change from all-time high	-46.76%
Change from all-time low	666.79%
Change from open	6.29%
Day's gap	0.9%
Dollar volume	HKD 106.2M
High price	HKD 44.72
Low price	HKD 40.40
Monthly RSI	54.13
Open price	HKD 40.40
Position in 52-week range	58.8%
Previous close	HKD 40.04
Price vs 150-day SMA	-21.46%
Price vs 20-day SMA	-24.54%
Price vs 200-day SMA	-18.75%
Price vs 50-day SMA	-28.36%
Relative volume	1.06
RSI	33.81
Sharpe ratio	1.11
Sharpe ratio (3Y)	0.81
Sortino ratio	1.95
Sortino ratio (3Y)	1.41
Volume	2.5M
Weekly RSI	41.4
YTD price change	21.64%
YTD total return	21.64%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	154.1M
Shares change (QoQ)	-3.9%
Shares change (YoY)	1.95%
Shares held by insiders	14.07%
Shares held by institutions	23.76%
Shares outstanding	446.9M

Deeper analysis on HKG/2315

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this HKG/2315 report

Is a complete HKG/2315 research report available?

No complete published report is available for hkg/2315 (HKG/2315) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

HKG/2315 (HKG/2315)

Price

Financial snapshot

Fair-value bridge

Latest news · HKG/2315

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All HKG/2315 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on HKG/2315

Frequently asked questions